Growth Metrics

Stereotaxis (STXS) Notes Payables (2020 - 2021)

Stereotaxis (STXS) reported Notes Payables of $1.9 million for Q1 2021, up 61.57% on a QoQ basis from $1.2 million in Q4 2020.

Stereotaxis (STXS) has 2 years of Notes Payables data on file, last reported at $1.9 million in Q1 2021.

  • Quarterly Notes Payables changed N/A year-over-year to $1.9 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $1.9 million (changed N/A YoY) and the FY2020 annual result came in at $1.2 million, changed N/A from the prior year.
  • Notes Payables grew to $1.9 million in Q1 2021 per STXS's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Notes Payables topped out at $2.2 million in Q2 2020 and bottomed at $457244.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2021 1.91 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 457,244.00
Jun 30, 2020 2.16 Mn